| MicroRNA‐1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone GP Diniz, CA Lino, CR Moreno, N Senger, MLM Barreto‐Chaves Journal of cellular physiology 232 (12), 3360-3368, 2017 | 37 | 2017 |
| Impact of hyperthyroidism on cardiac hypertrophy MLM Barreto-Chaves, N Senger, MR Fevereiro, AC Parletta, APC Takano Endocrine connections 9 (3), R59-R69, 2020 | 33 | 2020 |
| Renin–angiotensin system overactivation in perivascular adipose tissue contributes to vascular dysfunction in heart failure MT Fontes, SM Paula, CA Lino, N Senger, GK Couto, ... Clinical Science 134 (23), 3195-3211, 2020 | 30 | 2020 |
| Cardiac ACE2/angiotensin 1–7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy GP Diniz, N Senger, MS Carneiro-Ramos, RAS Santos, ... Therapeutic advances in cardiovascular disease 10 (4), 192-202, 2016 | 27 | 2016 |
| The endocrinological component and signaling pathways associated to cardiac hypertrophy APC Takano, N Senger, MLM Barreto-Chaves Molecular and Cellular Endocrinology, 110972, 2020 | 24 | 2020 |
| The relevance of thimet oligopeptidase in the regulation of energy metabolism and diet-induced obesity MCF Gewehr, AAS Teixeira, BAC Santos, LA Biondo, FC Gozzo, ... Biomolecules 10 (2), 321, 2020 | 19 | 2020 |
| Angiotensin‐(1‐7) prevents T3‐induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF‐ĸB N Senger, A C Parletta, BVD Marques, EH Akamine, GP Diniz, ... Journal of Cellular Physiology 236 (4), 3059-3072, 2021 | 16 | 2021 |
| Angiotensin-(1–7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway N Senger, MB Melo, GP Diniz, MJ Campagnole-Santos, RAS Santos, ... Clinical Science 132 (11), 1117-1133, 2018 | 15 | 2018 |
| AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes APC Takano, N Senger, CD Munhoz, MLM Barreto-Chaves Pflügers Archiv-European Journal of Physiology 470 (3), 549-558, 2018 | 12 | 2018 |
| Angiotensin II type 2 receptor mediates high fat diet-induced cardiomyocyte hypertrophy and hypercholesterolemia VM Lima, CA Lino, N Senger, T de Oliveira Silva, RIB Fonseca, M Bader, ... Molecular and cellular endocrinology 498, 110576, 2019 | 10 | 2019 |
| Hyperthyroidism and COVID-19: Cross-talk with the Renin-Angiotensin System N Senger, ML Barreto-Chaves Authorea Preprints, 2020 | 3 | 2020 |
| Angiotensin‐(1–7) Prevents cardiovascular changes induced by hyperthyroidism N Senger, MB Melo, MJC Santos, RA Santos, MLM Barreto‐Chaves The FASEB Journal 31, lb642-lb642, 2017 | 1 | 2017 |
| Angiotensin‐(1‐7) Prevents Thyroid Hormone‐induced Cardiomyocyte Hypertrophy by FOXO3 Signaling Pathway N Senger, RA Santos, MLM Barreto‐Chaves The FASEB Journal 33 (S1), 833.11-833.11, 2019 | | 2019 |
| Papel da angiotensina-(1-7) e das vias de sinalização PI3K/Akt/FOXO e PI3K/Akt/mTOR na hipertrofia cardiomiocítica induzida por hormônio tireoidiano. N Senger Universidade de São Paulo, 2019 | | 2019 |
| EARLIER KIDNEY INJURY ASSOSSIATED WITH HIGH FAT DIET FROM WEANING TO ADULT RATS AP de Oliveira Leite, CR Muller, N Senger, ALV Americo, RS Mateus, ... The FASEB Journal 26, 651.13-651.13, 2012 | | 2012 |
